Proteinuria as a mediator of tubulointerstitial injury

Kidney and Blood Pressure Research

Volumn 22, Issue 1-2, 1999, Pages 37-46

  Abbate, Mauro ^a   Remuzzi, Giuseppe ^b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b NONE

Author keywords

Angiotensin; Autoimmunity; Chemokines; Lymphocyte; MHC class II; Monocyte; Proteinuria

Indexed keywords

ANGIOTENSIN; CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; DISEASE COURSE; EPITHELIUM CELL; FIBROGENESIS; GLOMERULOPATHY; INFLAMMATION; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; LYMPHOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; DISEASE PROGRESSION; EPITHELIAL CELLS; HORMONES; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; METALS; PROTEINURIA;

EID: 0032978264     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025907     Document Type: Article

References (101)

1. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
2. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
3. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
4. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H: Long-term prognosis of focal sclerosis glomerulonephritis: An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990; 33:115-122.
5. Mackensen-Haen R, Eissele R, Bohle A: Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis. Lab Invest 1988;59:239-244.
6. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Muller CA, Muller GA: The pathogenesis of chronic renal failure in diabetic nephropathy: Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 1991; 187:251-259.
7. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gartner H-V: Long-term prognosis of chronic idiopathic membranous glomerulonephritis. Clin Nephrol 1989;31:67-76.
8. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlation in renal disease. II. The correlations. Hum Pathol 1970; 1:631-641.
9. Mackensen-Haen S, Bohle A, Christensen J, Wehrmann M, Kendziorra H, Kokot F: The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992; 37:70-77.
10. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-496.
11. Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G: Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein contents. Lab Invest 1989;60:196-204.
12. Brown DM, Steffes MW, Thibert P, Azar S, Mauer SM: Glomerular manifestations of diabetes in the BB rat. Metabolism 1983;32:131-135.
13. Cohen AJ, McCarthy DM, Rossetti RG: Renin secretion of the spontaneously diabetic rat. Diabetes 1986;35:341-345.
14. Magil AB: Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 1995;25:478-485.
15. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998;9:1213-1224.
16. Eddy AA, McCulloch L, Adams J, Liu E: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989;135:719-733.
17. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47:1546-1557.
18. Mori H, Yamashita H, Nakanishi C, Koizumi K, Makino S, Kishimoto Y, et al: Proteinuria induced by transplantable rat pituitary tumor MtT SA5. Model for homologous protein overload proteinuria. Lab Invest 1986;54:636-644.
19. Kikuchi H, Kawachi H, Saito A, Orikasa M, Arakawa M, Shimizu F: Severe proteinuria sustained for six months induced tubular epithelial cell injury and cell infiltration but not interstitial fibrosis (abstract). J Am Soc Nephrol 1998;9:500A.
20. Zoja C, Remuzzi A, Corna D, Perico N, Bertani T, Remuzzi G: Renal protective effect of angiotensin-converting enzyme inhibition in aging rats. Am J Med 1992;92(suppl 4B): 60S-63S.
21. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85:541-549.
22. Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 1994;2:220-228.
23. Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A: Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 1996;4:213-221.
24. Macconi D, Ghilardi M, Abbate M, Morigi M, Bonassi M, Remuzzi G, Remuzzi A: Lisinopril (LIS) prevents alteration in glomerular distribution of zonula occludens 1 (ZO-1) that develop in proteinuric MWF rats (abstract). J Am Soc Nephrol 1998;9:502A.
25. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38: 384-394.
26. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
27. The Gisen Group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-1863.
28. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G, on behalf of GISEN: Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 1998; 352:1252-1256.
29. Morelli E, Loon NR, Meyer TW, Peters W, Myers BD: Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:76-82.
30. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 1993;6: 36-43.
31. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991;39:1267-1273.
32. Park CH, Maack T: Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 1984;73:767.
33. Olbricht CJ, Cannon JK, Garg LC, Tisher CC: Activities of cathepsin B and L in isolated nephron segments from proteinuric and non proteinuric rats. Am J Physiol 1986;250: F1055-F1062.
34. Maack T, Park CH, Camargo MJF: Renal filtration, transport, and metabolism of proteins: in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology, New York, Raven Press, 1985, pp 1773-1803.
35. Brunskill NJ, Cockcroft N, Nahorski S, Walls J: Albumin endocytosis is regulated by heterotrimeric GTP-binding protein Gαi-3 in opossum kidney cells. Am J Physiol 1996;271: F356-F364.
36. Brunskill NJ, Stuart J, Tobin AB, Walls J, Nahorski S: Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase. J Clin Invest 1998;101:2140-2150.
37. Cessac-Guillemet AL, Mounier F, Borot C, Bakala H, Perichon M, Schaeverbeke M, Schaeverbeke J: Characterization and distribution of albumin binding protein in normal rat kidney. Am J Physiol 1996;271:F101-F107.
38. Cui S, Verroust PJ, Moestrup SK, Christensen EI: Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol 1996;271:-F900-F907.
39. Haymann J-P, Bouet S, Levraud J-P, Kappes V, Hagège J, Nguyen G, Rondeau E, Bjorkman P, Sraer J-D: Characterization of the neonatal Fc receptor (FcRn) on cultured human glomerular epithelial cells. Localization of FcRn in normal human kidney (abstract). J Am Soc Nephrol 1997;8:456A.
40. Ong ACM, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG: A new paracrine loop implicated in human tubulo-interstitial fibrosis: Tubular-derived endothelins modulate renal interstitial fibroblast function (abstract). J Am Soc Nephrol 1993;4:473.
41. Achmad TH, Rao GS: Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem Biophys Res Commun 1992;189: 994-1000.
42. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco PM, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
43. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993;43:354-358.
44. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440-444.
45. Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, Benigni A: Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 1997;151:1241-1247.
46. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, et al.: Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 1993;122: 149-156.
47. Benigni A, Zoja C, Corna D, Orisio S, Facchinetti D, Benatti L, et al: Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am J Kidney Dis 1996;27:416-423.
48. Gomez-Garre D, Largo R, Liu XH, Gutierrez S, Lopez-Armada MJ, Palacios I, et al: An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int 1996;50:962-972.
49. Zoja C, Liu X-H, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A: Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy. Exp Nephrol 1998; 6:121-131.
50. Wang Y, Chen J, Chen L, Tay Y-C, Rangan GK, Harris DCH: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997;8:1537-1545.
51. Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 1997;15:675-705.
52. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB activation. Kidney Int 1998;53:1608-1615.
53. Tang WW, Qi M, Warren JS, Van GY: Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 1997;159: 870-876.
54. Lloyd CM, Minto AW, Dorff ME, Proudfoot A, Wells TNC, Salant DJ, Gutierrez-Ramos J-C: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997;185: 1371-1380.
55. Eddy AA: Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 1996;49(suppl 54):S49-S54.
56. Abbate M, Bertani T: New insights into the pathogenesis of tubulointerstitial damage; in Tetta C (ed): Immunopharmacology of the Renal System. London, Academic Press, 1993, pp 21-34.
57. Hirano K, Utsunomiya Y, Kawamura T, Kawaguchi Y, Hosoya T: A rule of osteopontin expression in proximal tubular cells on the long-term prognosis of IgA nephropathy (abstract). J Am Soc Nephrol 1998;9:90A.
58. Yu XQ, Yuan QY, Guan WM, Nikolic-Paterson DJ, Hoyer JR, Atkins RC, Lan HY: Osteopontin expression in human glomerulonephritis (GN) (abstract). J Am Soc Nephrol 1998;9: 540A.
59. Mezzano S, Droguett MA, Burgos ME, Ardiles L, Caorsi I, Egido J: In situ detection of chemokines (MCP-1. RANTES, IL-8), osteopontin, fibrogenic cytokines (PDGF, TGF-β) and apoptotic cells in human idiopathic membranous nephropathy (MN) (abstract). J Am Soc Nephrol 1998;9:463A.
60. Tucker BJ, Rasch R, Blantz RC: Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats. J Clin Invest 1993;92:686-694.
61. Barnes PJ, Karin M: Nuclear factor-kB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;356:1066-1071.
62. Donadelli R, Zoja C, Benigni A, Bruzzi I, Abbate M, Balducci D, Zanchi C, Remuzzi G: ACE inhibition while reducing proteinuria also suppresses NF-kB activation and reduces renal MCP-1 in rats with remnant kidney (abstract). J Am Soc Nephrol 1998;9:453A.
63. Hirschberg R: Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions. J Clin Invest 1997;98:116-124.
64. Kees-Folts D, Sadow JL, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994;45:1697-1709.
65. Schreiner GF: Renal toxicity of albumin and other lipoproteins. Curr Opin Nephrol Hyperten 1995;4:369-373.
66. Zager RA, Schimpf BA, Bredl CR, Gmur DJ: Inorganic iron effects on in vitro hypoxic proximal tubular cell injury. J Clin Invest 1993;91: 702-708.
67. Harris DCH, Chen L, Tay C, Chen J, Nankivell BJ: Cytotoxicity of reabsorbed protein in proximal tubule (PT) by peroxidation (abstract). J Am Soc Nephrol 1994;5:944.
68. Nomura A, Morita Y, Maruyama S, Hotta N, Nadai M, Wang L, Hasegawa T, Matsuo S: Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol 1997;151:539-547.
69. Nath K, Hostetter MK, Hostetter TH: Pathophysiology of chronic tubulo-interstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985;76:667-675.
70. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA: In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 1982;128:1659-1663.
71. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G: Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994;45:451-160.
72. David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G: Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 1997;12: 51-56.
73. Hostetter MK, Gordon DL: Biochemistry of C3 and related thioester proteins in infection and inflammation. Rev Infect Dis 1987;9:97-109.
74. Isenman DE, Kells DIC, Cooper NR, Muller-Eberhard J, Pangburn MK: Nucleophilic modification of human complement protein C3: Correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry 1991;20:4458-4467.
75. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S: Localization of the complement regulatory proteins in the normal kidney. Kidney Int 1994;46:89-96.
76. Abe K, Miyazaki M, Koji T, Furusu A, Ozono Y, Harada T, Sakai H, Nakane PK, Kohno S: Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. Kidney Int 1998;54:120-130.
77. Brooimans RA, Stegmann APA, van Dorp WT, van der Ark AAJ, van der Woude FJ, van Es LA, Daha MR: Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991;88:379-384.
78. Sasaki O, Zhou W, Miyazaki M, Abe K, Koji T, Verroust P, Tsukasaki S, Ozono Y, Harada T, Nakane PK, Kohno S, Sacks SK: Intraglomerular C3 synthesis in rats with passive Heymann nephritis. Am J Pathol 1997;151: 1249-1256.
79. Sheerin NS, Zhou W, Brown Z, Sacks SH: Apical proteins stimulate complement synthesis in cultured human proximal tubular epithelial cells (abstract). J Am Soc Nephrol 1998;9: 622A.
80. Abbate M, Zoja C, Rottoli D, Corna D, Benedetti G, Bertani T, Remuzzi G: ACE-inhibition protects rats with reduction of renal mass (RMR) against tubular complement deposition and interstitial inflammation (abstract). J Am Soc Nephrol 1998;9:602A.
81. Benigni A, Abbate M, Gagliardini E, Marchetti G, Corna D, Zoja C, Remuzzi G: In rats with renal mass reduction (RMR) protein-dependent interstitial accumulation of T-cells and macrophages is limited by antiproteinuric drugs (abstract). J Am Soc Nephrol 1998;9: 472A.
82. Morita Y, Nomura A, Yuzawa Y, Nishikawa K, Hotta N, Shimizu F, Matsuo S: The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1997;8: 1363-1372.
83. Strutz F, Okada H, Lo CW: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995;130:393-405.
84. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996;49:666-678.
85. Gandhi M, Olson JL, Meyer TW: Contribution of tubular injury to loss of remnant kidney function. Kidney Int 1998;54:1157-1165.
86. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 1998;54:687-697.
87. Strutz F, Müller GA, Neilson EG: Transdifferentiation: A new angle on renal fibrosis. Exp Nephrol 1996;4:267-270.
88. Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 1998;54:747-757.
89. Eddy A: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-2508.
90. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. New Engl J Med 1994;331:1286-1292.
91. Postlethwaite AE, Holness MA, Katai H, Raghow R: Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992; 90:1479-1485.
92. Sharma K, Ziyadeh FN: The transforming growth factor-β system and the kidney. Semin Nephrol 1993;13:116-128.
93. Hagerty DT, Allen PM: Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 1992;148: 2324-2330.
94. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanbe M, Harper RA, Kefalides NA, Neilson EG: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 1988; 107:1359-1368.
95. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
96. Mosialos G, Birkenbach H, Ayehunie S, et al: Circulating human dendritic cells differentially express high levels of a 55-kd actinbundling protein. Am J Pathol 1996;148:593.
97. Sonderbye L, Meehan S, Palsson R, Ahsan N, Ladefoged J, Langhoff E: Immunohistochemical study of actin binding protein (p55) in the human kidney. Transplantation 1998;65: 1004-1008.
98. Eugui EM, Mirkovich A, Allison AC: Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol 1991;33: 175-183.
99. Zoja C, Corna D, Benigni A, Rossi P, Abbate M, Rottoli D, Marchetti G, Bertani T, Remuzzi G: The effect of lisinopril, mycophenolate mofetil (MMF) and their combination on renal disease progression in rats with remnant kidney (RMR) (abstract). J Am Soc Nephrol 1998;9:49IA.
100. Rubin-Kelley VE, Jevnikar AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 1991;2:13-26.
101. Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G: Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. Kidney Int 1998;54:353-359.